nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2C19—Vismodegib—skin cancer	0.205	0.328	CbGbCtD
Metoprolol—ABCB1—Vismodegib—skin cancer	0.166	0.265	CbGbCtD
Metoprolol—CYP2D6—Vemurafenib—skin cancer	0.123	0.197	CbGbCtD
Metoprolol—ABCB1—Dactinomycin—skin cancer	0.087	0.139	CbGbCtD
Metoprolol—ABCB1—Docetaxel—skin cancer	0.0449	0.0717	CbGbCtD
Metoprolol—Tachycardia—Imiquimod—skin cancer	0.000956	0.00256	CcSEcCtD
Metoprolol—Skin disorder—Imiquimod—skin cancer	0.000951	0.00254	CcSEcCtD
Metoprolol—Erectile dysfunction—Temozolomide—skin cancer	0.00095	0.00254	CcSEcCtD
Metoprolol—Agranulocytosis—Dactinomycin—skin cancer	0.000949	0.00254	CcSEcCtD
Metoprolol—Hyperhidrosis—Imiquimod—skin cancer	0.000947	0.00253	CcSEcCtD
Metoprolol—Photosensitivity reaction—Temozolomide—skin cancer	0.000942	0.00252	CcSEcCtD
Metoprolol—Weight increased—Temozolomide—skin cancer	0.000939	0.00251	CcSEcCtD
Metoprolol—Angina pectoris—Fluorouracil—skin cancer	0.000926	0.00248	CcSEcCtD
Metoprolol—Pneumonia—Temozolomide—skin cancer	0.000925	0.00247	CcSEcCtD
Metoprolol—Depression—Temozolomide—skin cancer	0.000917	0.00245	CcSEcCtD
Metoprolol—Hepatitis—Dactinomycin—skin cancer	0.000913	0.00244	CcSEcCtD
Metoprolol—Body temperature increased—Vemurafenib—skin cancer	0.000908	0.00243	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000892	0.00239	CcSEcCtD
Metoprolol—Deafness—Docetaxel—skin cancer	0.000887	0.00237	CcSEcCtD
Metoprolol—Insomnia—Imiquimod—skin cancer	0.000886	0.00237	CcSEcCtD
Metoprolol—Paraesthesia—Imiquimod—skin cancer	0.000879	0.00235	CcSEcCtD
Metoprolol—Cardiac failure congestive—Docetaxel—skin cancer	0.000875	0.00234	CcSEcCtD
Metoprolol—Dyspnoea—Imiquimod—skin cancer	0.000873	0.00233	CcSEcCtD
Metoprolol—Somnolence—Imiquimod—skin cancer	0.00087	0.00233	CcSEcCtD
Metoprolol—Hepatobiliary disease—Temozolomide—skin cancer	0.00087	0.00233	CcSEcCtD
Metoprolol—Photosensitivity reaction—Fluorouracil—skin cancer	0.000868	0.00232	CcSEcCtD
Metoprolol—Alopecia—Bleomycin—skin cancer	0.000865	0.00231	CcSEcCtD
Metoprolol—Dyspepsia—Imiquimod—skin cancer	0.000862	0.0023	CcSEcCtD
Metoprolol—Pneumonia—Fluorouracil—skin cancer	0.000853	0.00228	CcSEcCtD
Metoprolol—Hot flush—Docetaxel—skin cancer	0.000849	0.00227	CcSEcCtD
Metoprolol—Hypersensitivity—Vemurafenib—skin cancer	0.000846	0.00226	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Imiquimod—skin cancer	0.000845	0.00226	CcSEcCtD
Metoprolol—Fatigue—Imiquimod—skin cancer	0.000844	0.00226	CcSEcCtD
Metoprolol—Menopausal symptoms—Docetaxel—skin cancer	0.000841	0.00225	CcSEcCtD
Metoprolol—Visual disturbance—Docetaxel—skin cancer	0.000838	0.00224	CcSEcCtD
Metoprolol—Pain—Imiquimod—skin cancer	0.000837	0.00224	CcSEcCtD
Metoprolol—Hepatitis—Temozolomide—skin cancer	0.000826	0.00221	CcSEcCtD
Metoprolol—Conjunctivitis—Fluorouracil—skin cancer	0.000824	0.0022	CcSEcCtD
Metoprolol—Asthenia—Vemurafenib—skin cancer	0.000824	0.0022	CcSEcCtD
Metoprolol—Hallucination—Temozolomide—skin cancer	0.000822	0.0022	CcSEcCtD
Metoprolol—Oedema peripheral—Temozolomide—skin cancer	0.000814	0.00218	CcSEcCtD
Metoprolol—Cardiac failure—Docetaxel—skin cancer	0.000813	0.00218	CcSEcCtD
Metoprolol—Pruritus—Vemurafenib—skin cancer	0.000812	0.00217	CcSEcCtD
Metoprolol—Connective tissue disorder—Temozolomide—skin cancer	0.000812	0.00217	CcSEcCtD
Metoprolol—Alopecia—Dactinomycin—skin cancer	0.000807	0.00216	CcSEcCtD
Metoprolol—Feeling abnormal—Imiquimod—skin cancer	0.000807	0.00216	CcSEcCtD
Metoprolol—Gastrointestinal pain—Imiquimod—skin cancer	0.000801	0.00214	CcSEcCtD
Metoprolol—Visual impairment—Temozolomide—skin cancer	0.000796	0.00213	CcSEcCtD
Metoprolol—Agranulocytosis—Fluorouracil—skin cancer	0.000791	0.00212	CcSEcCtD
Metoprolol—Diarrhoea—Vemurafenib—skin cancer	0.000786	0.0021	CcSEcCtD
Metoprolol—Urticaria—Imiquimod—skin cancer	0.000778	0.00208	CcSEcCtD
Metoprolol—Abdominal pain—Imiquimod—skin cancer	0.000774	0.00207	CcSEcCtD
Metoprolol—Body temperature increased—Imiquimod—skin cancer	0.000774	0.00207	CcSEcCtD
Metoprolol—Eye disorder—Temozolomide—skin cancer	0.000772	0.00206	CcSEcCtD
Metoprolol—Tinnitus—Temozolomide—skin cancer	0.00077	0.00206	CcSEcCtD
Metoprolol—Cardiac disorder—Temozolomide—skin cancer	0.000766	0.00205	CcSEcCtD
Metoprolol—Leukopenia—Bleomycin—skin cancer	0.000763	0.00204	CcSEcCtD
Metoprolol—Rhinitis—Fluorouracil—skin cancer	0.000763	0.00204	CcSEcCtD
Metoprolol—Dizziness—Vemurafenib—skin cancer	0.000759	0.00203	CcSEcCtD
Metoprolol—Angiopathy—Temozolomide—skin cancer	0.000749	0.002	CcSEcCtD
Metoprolol—Immune system disorder—Temozolomide—skin cancer	0.000746	0.00199	CcSEcCtD
Metoprolol—Mediastinal disorder—Temozolomide—skin cancer	0.000744	0.00199	CcSEcCtD
Metoprolol—Liver function test abnormal—Docetaxel—skin cancer	0.000733	0.00196	CcSEcCtD
Metoprolol—Vomiting—Vemurafenib—skin cancer	0.00073	0.00195	CcSEcCtD
Metoprolol—Alopecia—Temozolomide—skin cancer	0.00073	0.00195	CcSEcCtD
Metoprolol—Chest pain—Bleomycin—skin cancer	0.000726	0.00194	CcSEcCtD
Metoprolol—Abdominal pain upper—Docetaxel—skin cancer	0.000725	0.00194	CcSEcCtD
Metoprolol—Orthostatic hypotension—Docetaxel—skin cancer	0.000725	0.00194	CcSEcCtD
Metoprolol—Rash—Vemurafenib—skin cancer	0.000724	0.00194	CcSEcCtD
Metoprolol—Mental disorder—Temozolomide—skin cancer	0.000724	0.00193	CcSEcCtD
Metoprolol—Dermatitis—Vemurafenib—skin cancer	0.000723	0.00193	CcSEcCtD
Metoprolol—Hypersensitivity—Imiquimod—skin cancer	0.000721	0.00193	CcSEcCtD
Metoprolol—Headache—Vemurafenib—skin cancer	0.000719	0.00192	CcSEcCtD
Metoprolol—Breast disorder—Docetaxel—skin cancer	0.000717	0.00192	CcSEcCtD
Metoprolol—Cramp muscle—Docetaxel—skin cancer	0.000715	0.00191	CcSEcCtD
Metoprolol—Leukopenia—Dactinomycin—skin cancer	0.000711	0.0019	CcSEcCtD
Metoprolol—Dysgeusia—Temozolomide—skin cancer	0.000704	0.00188	CcSEcCtD
Metoprolol—Asthenia—Imiquimod—skin cancer	0.000702	0.00188	CcSEcCtD
Metoprolol—Confusional state—Bleomycin—skin cancer	0.000701	0.00188	CcSEcCtD
Metoprolol—Oedema—Bleomycin—skin cancer	0.000696	0.00186	CcSEcCtD
Metoprolol—Pruritus—Imiquimod—skin cancer	0.000693	0.00185	CcSEcCtD
Metoprolol—Nausea—Vemurafenib—skin cancer	0.000682	0.00182	CcSEcCtD
Metoprolol—Thrombocytopenia—Bleomycin—skin cancer	0.000681	0.00182	CcSEcCtD
Metoprolol—Arrhythmia—Fluorouracil—skin cancer	0.00068	0.00182	CcSEcCtD
Metoprolol—Vision blurred—Temozolomide—skin cancer	0.000678	0.00181	CcSEcCtD
Metoprolol—Bronchospasm—Docetaxel—skin cancer	0.000675	0.0018	CcSEcCtD
Metoprolol—Alopecia—Fluorouracil—skin cancer	0.000672	0.0018	CcSEcCtD
Metoprolol—Diarrhoea—Imiquimod—skin cancer	0.00067	0.00179	CcSEcCtD
Metoprolol—Angina pectoris—Docetaxel—skin cancer	0.000668	0.00179	CcSEcCtD
Metoprolol—Hypotension—Bleomycin—skin cancer	0.00065	0.00174	CcSEcCtD
Metoprolol—Oedema—Dactinomycin—skin cancer	0.000649	0.00173	CcSEcCtD
Metoprolol—Dizziness—Imiquimod—skin cancer	0.000647	0.00173	CcSEcCtD
Metoprolol—Vertigo—Temozolomide—skin cancer	0.000646	0.00173	CcSEcCtD
Metoprolol—Leukopenia—Temozolomide—skin cancer	0.000644	0.00172	CcSEcCtD
Metoprolol—Palpitations—Temozolomide—skin cancer	0.000635	0.0017	CcSEcCtD
Metoprolol—Thrombocytopenia—Dactinomycin—skin cancer	0.000635	0.0017	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000634	0.00169	CcSEcCtD
Metoprolol—Paraesthesia—Bleomycin—skin cancer	0.000625	0.00167	CcSEcCtD
Metoprolol—Weight increased—Docetaxel—skin cancer	0.000624	0.00167	CcSEcCtD
Metoprolol—Vision blurred—Fluorouracil—skin cancer	0.000624	0.00167	CcSEcCtD
Metoprolol—Vomiting—Imiquimod—skin cancer	0.000623	0.00166	CcSEcCtD
Metoprolol—Hypertension—Temozolomide—skin cancer	0.000621	0.00166	CcSEcCtD
Metoprolol—Dyspnoea—Bleomycin—skin cancer	0.00062	0.00166	CcSEcCtD
Metoprolol—Rash—Imiquimod—skin cancer	0.000617	0.00165	CcSEcCtD
Metoprolol—Dermatitis—Imiquimod—skin cancer	0.000617	0.00165	CcSEcCtD
Metoprolol—Pneumonia—Docetaxel—skin cancer	0.000615	0.00165	CcSEcCtD
Metoprolol—Headache—Imiquimod—skin cancer	0.000613	0.00164	CcSEcCtD
Metoprolol—Arthralgia—Temozolomide—skin cancer	0.000612	0.00164	CcSEcCtD
Metoprolol—Anxiety—Temozolomide—skin cancer	0.00061	0.00163	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000608	0.00163	CcSEcCtD
Metoprolol—Dry mouth—Temozolomide—skin cancer	0.000599	0.0016	CcSEcCtD
Metoprolol—Jaundice—Docetaxel—skin cancer	0.000596	0.00159	CcSEcCtD
Metoprolol—Pain—Bleomycin—skin cancer	0.000595	0.00159	CcSEcCtD
Metoprolol—Conjunctivitis—Docetaxel—skin cancer	0.000595	0.00159	CcSEcCtD
Metoprolol—Leukopenia—Fluorouracil—skin cancer	0.000593	0.00159	CcSEcCtD
Metoprolol—Confusional state—Temozolomide—skin cancer	0.000592	0.00158	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000591	0.00158	CcSEcCtD
Metoprolol—Oedema—Temozolomide—skin cancer	0.000587	0.00157	CcSEcCtD
Metoprolol—Nausea—Imiquimod—skin cancer	0.000582	0.00156	CcSEcCtD
Metoprolol—Hepatobiliary disease—Docetaxel—skin cancer	0.000579	0.00155	CcSEcCtD
Metoprolol—Nervous system disorder—Temozolomide—skin cancer	0.000575	0.00154	CcSEcCtD
Metoprolol—Thrombocytopenia—Temozolomide—skin cancer	0.000574	0.00154	CcSEcCtD
Metoprolol—Feeling abnormal—Bleomycin—skin cancer	0.000573	0.00153	CcSEcCtD
Metoprolol—Agranulocytosis—Docetaxel—skin cancer	0.000571	0.00153	CcSEcCtD
Metoprolol—Skin disorder—Temozolomide—skin cancer	0.00057	0.00152	CcSEcCtD
Metoprolol—Hyperhidrosis—Temozolomide—skin cancer	0.000567	0.00152	CcSEcCtD
Metoprolol—Chest pain—Fluorouracil—skin cancer	0.000564	0.00151	CcSEcCtD
Metoprolol—Fatigue—Dactinomycin—skin cancer	0.000559	0.0015	CcSEcCtD
Metoprolol—Pain—Dactinomycin—skin cancer	0.000555	0.00148	CcSEcCtD
Metoprolol—Urticaria—Bleomycin—skin cancer	0.000553	0.00148	CcSEcCtD
Metoprolol—Rhinitis—Docetaxel—skin cancer	0.000551	0.00147	CcSEcCtD
Metoprolol—Body temperature increased—Bleomycin—skin cancer	0.00055	0.00147	CcSEcCtD
Metoprolol—Hepatitis—Docetaxel—skin cancer	0.000549	0.00147	CcSEcCtD
Metoprolol—Confusional state—Fluorouracil—skin cancer	0.000545	0.00146	CcSEcCtD
Metoprolol—Oedema peripheral—Docetaxel—skin cancer	0.000541	0.00145	CcSEcCtD
Metoprolol—Oedema—Fluorouracil—skin cancer	0.000541	0.00145	CcSEcCtD
Metoprolol—Connective tissue disorder—Docetaxel—skin cancer	0.00054	0.00144	CcSEcCtD
Metoprolol—Feeling abnormal—Dactinomycin—skin cancer	0.000535	0.00143	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000535	0.00143	CcSEcCtD
Metoprolol—Insomnia—Temozolomide—skin cancer	0.000531	0.00142	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dactinomycin—skin cancer	0.00053	0.00142	CcSEcCtD
Metoprolol—Nervous system disorder—Fluorouracil—skin cancer	0.00053	0.00142	CcSEcCtD
Metoprolol—Thrombocytopenia—Fluorouracil—skin cancer	0.000529	0.00142	CcSEcCtD
Metoprolol—Visual impairment—Docetaxel—skin cancer	0.000529	0.00142	CcSEcCtD
Metoprolol—Tachycardia—Fluorouracil—skin cancer	0.000528	0.00141	CcSEcCtD
Metoprolol—Paraesthesia—Temozolomide—skin cancer	0.000527	0.00141	CcSEcCtD
Metoprolol—Dyspnoea—Temozolomide—skin cancer	0.000523	0.0014	CcSEcCtD
Metoprolol—Somnolence—Temozolomide—skin cancer	0.000522	0.00139	CcSEcCtD
Metoprolol—Dyspepsia—Temozolomide—skin cancer	0.000516	0.00138	CcSEcCtD
Metoprolol—Eye disorder—Docetaxel—skin cancer	0.000513	0.00137	CcSEcCtD
Metoprolol—Abdominal pain—Dactinomycin—skin cancer	0.000513	0.00137	CcSEcCtD
Metoprolol—Body temperature increased—Dactinomycin—skin cancer	0.000513	0.00137	CcSEcCtD
Metoprolol—Hypersensitivity—Bleomycin—skin cancer	0.000512	0.00137	CcSEcCtD
Metoprolol—Cardiac disorder—Docetaxel—skin cancer	0.00051	0.00136	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Temozolomide—skin cancer	0.000507	0.00135	CcSEcCtD
Metoprolol—Fatigue—Temozolomide—skin cancer	0.000506	0.00135	CcSEcCtD
Metoprolol—Hypotension—Fluorouracil—skin cancer	0.000505	0.00135	CcSEcCtD
Metoprolol—Pain—Temozolomide—skin cancer	0.000502	0.00134	CcSEcCtD
Metoprolol—Constipation—Temozolomide—skin cancer	0.000502	0.00134	CcSEcCtD
Metoprolol—Asthenia—Bleomycin—skin cancer	0.000499	0.00133	CcSEcCtD
Metoprolol—Angiopathy—Docetaxel—skin cancer	0.000498	0.00133	CcSEcCtD
Metoprolol—Immune system disorder—Docetaxel—skin cancer	0.000496	0.00133	CcSEcCtD
Metoprolol—Mediastinal disorder—Docetaxel—skin cancer	0.000495	0.00132	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000493	0.00132	CcSEcCtD
Metoprolol—Pruritus—Bleomycin—skin cancer	0.000492	0.00132	CcSEcCtD
Metoprolol—Arrhythmia—Docetaxel—skin cancer	0.000491	0.00131	CcSEcCtD
Metoprolol—Insomnia—Fluorouracil—skin cancer	0.000489	0.00131	CcSEcCtD
Metoprolol—Paraesthesia—Fluorouracil—skin cancer	0.000485	0.0013	CcSEcCtD
Metoprolol—Alopecia—Docetaxel—skin cancer	0.000485	0.0013	CcSEcCtD
Metoprolol—Feeling abnormal—Temozolomide—skin cancer	0.000484	0.00129	CcSEcCtD
Metoprolol—Dyspnoea—Fluorouracil—skin cancer	0.000482	0.00129	CcSEcCtD
Metoprolol—Mental disorder—Docetaxel—skin cancer	0.000481	0.00129	CcSEcCtD
Metoprolol—Somnolence—Fluorouracil—skin cancer	0.000481	0.00129	CcSEcCtD
Metoprolol—Gastrointestinal pain—Temozolomide—skin cancer	0.00048	0.00128	CcSEcCtD
Metoprolol—Hypersensitivity—Dactinomycin—skin cancer	0.000478	0.00128	CcSEcCtD
Metoprolol—Dyspepsia—Fluorouracil—skin cancer	0.000476	0.00127	CcSEcCtD
Metoprolol—Dysgeusia—Docetaxel—skin cancer	0.000468	0.00125	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000467	0.00125	CcSEcCtD
Metoprolol—Urticaria—Temozolomide—skin cancer	0.000466	0.00125	CcSEcCtD
Metoprolol—Asthenia—Dactinomycin—skin cancer	0.000465	0.00124	CcSEcCtD
Metoprolol—Abdominal pain—Temozolomide—skin cancer	0.000464	0.00124	CcSEcCtD
Metoprolol—Body temperature increased—Temozolomide—skin cancer	0.000464	0.00124	CcSEcCtD
Metoprolol—Pain—Fluorouracil—skin cancer	0.000462	0.00124	CcSEcCtD
Metoprolol—Muscle spasms—Docetaxel—skin cancer	0.00046	0.00123	CcSEcCtD
Metoprolol—Feeling abnormal—Fluorouracil—skin cancer	0.000445	0.00119	CcSEcCtD
Metoprolol—Diarrhoea—Dactinomycin—skin cancer	0.000444	0.00119	CcSEcCtD
Metoprolol—Vomiting—Bleomycin—skin cancer	0.000442	0.00118	CcSEcCtD
Metoprolol—Rash—Bleomycin—skin cancer	0.000439	0.00117	CcSEcCtD
Metoprolol—Dermatitis—Bleomycin—skin cancer	0.000438	0.00117	CcSEcCtD
Metoprolol—Hypersensitivity—Temozolomide—skin cancer	0.000432	0.00116	CcSEcCtD
Metoprolol—Urticaria—Fluorouracil—skin cancer	0.000429	0.00115	CcSEcCtD
Metoprolol—Syncope—Docetaxel—skin cancer	0.000429	0.00115	CcSEcCtD
Metoprolol—Leukopenia—Docetaxel—skin cancer	0.000428	0.00114	CcSEcCtD
Metoprolol—Body temperature increased—Fluorouracil—skin cancer	0.000427	0.00114	CcSEcCtD
Metoprolol—Palpitations—Docetaxel—skin cancer	0.000422	0.00113	CcSEcCtD
Metoprolol—Asthenia—Temozolomide—skin cancer	0.000421	0.00113	CcSEcCtD
Metoprolol—Loss of consciousness—Docetaxel—skin cancer	0.00042	0.00112	CcSEcCtD
Metoprolol—Pruritus—Temozolomide—skin cancer	0.000415	0.00111	CcSEcCtD
Metoprolol—Nausea—Bleomycin—skin cancer	0.000413	0.0011	CcSEcCtD
Metoprolol—Hypertension—Docetaxel—skin cancer	0.000413	0.0011	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—skin cancer	0.000412	0.0011	CcSEcCtD
Metoprolol—Rash—Dactinomycin—skin cancer	0.000409	0.00109	CcSEcCtD
Metoprolol—Arthralgia—Docetaxel—skin cancer	0.000407	0.00109	CcSEcCtD
Metoprolol—Chest pain—Docetaxel—skin cancer	0.000407	0.00109	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000404	0.00108	CcSEcCtD
Metoprolol—Diarrhoea—Temozolomide—skin cancer	0.000401	0.00107	CcSEcCtD
Metoprolol—Hypersensitivity—Fluorouracil—skin cancer	0.000398	0.00107	CcSEcCtD
Metoprolol—Dry mouth—Docetaxel—skin cancer	0.000398	0.00106	CcSEcCtD
Metoprolol—Confusional state—Docetaxel—skin cancer	0.000393	0.00105	CcSEcCtD
Metoprolol—Oedema—Docetaxel—skin cancer	0.00039	0.00104	CcSEcCtD
Metoprolol—Dizziness—Temozolomide—skin cancer	0.000388	0.00104	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—skin cancer	0.000385	0.00103	CcSEcCtD
Metoprolol—Shock—Docetaxel—skin cancer	0.000384	0.00103	CcSEcCtD
Metoprolol—Nervous system disorder—Docetaxel—skin cancer	0.000383	0.00102	CcSEcCtD
Metoprolol—Pruritus—Fluorouracil—skin cancer	0.000382	0.00102	CcSEcCtD
Metoprolol—Thrombocytopenia—Docetaxel—skin cancer	0.000382	0.00102	CcSEcCtD
Metoprolol—Tachycardia—Docetaxel—skin cancer	0.000381	0.00102	CcSEcCtD
Metoprolol—Skin disorder—Docetaxel—skin cancer	0.000379	0.00101	CcSEcCtD
Metoprolol—Vomiting—Temozolomide—skin cancer	0.000373	0.000998	CcSEcCtD
Metoprolol—Rash—Temozolomide—skin cancer	0.00037	0.000989	CcSEcCtD
Metoprolol—Diarrhoea—Fluorouracil—skin cancer	0.00037	0.000989	CcSEcCtD
Metoprolol—Dermatitis—Temozolomide—skin cancer	0.00037	0.000988	CcSEcCtD
Metoprolol—Headache—Temozolomide—skin cancer	0.000368	0.000983	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—skin cancer	0.000365	0.000975	CcSEcCtD
Metoprolol—Dizziness—Fluorouracil—skin cancer	0.000357	0.000956	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000355	0.000951	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—skin cancer	0.000353	0.000944	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—skin cancer	0.00035	0.000937	CcSEcCtD
Metoprolol—Nausea—Temozolomide—skin cancer	0.000349	0.000932	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—skin cancer	0.000348	0.00093	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—skin cancer	0.000347	0.000928	CcSEcCtD
Metoprolol—Vomiting—Fluorouracil—skin cancer	0.000344	0.000919	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—skin cancer	0.000343	0.000918	CcSEcCtD
Metoprolol—Rash—Fluorouracil—skin cancer	0.000341	0.000911	CcSEcCtD
Metoprolol—Dermatitis—Fluorouracil—skin cancer	0.000341	0.000911	CcSEcCtD
Metoprolol—Headache—Fluorouracil—skin cancer	0.000339	0.000906	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—skin cancer	0.000337	0.000901	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—skin cancer	0.000336	0.0009	CcSEcCtD
Metoprolol—Pain—Docetaxel—skin cancer	0.000334	0.000892	CcSEcCtD
Metoprolol—Constipation—Docetaxel—skin cancer	0.000334	0.000892	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—skin cancer	0.000322	0.00086	CcSEcCtD
Metoprolol—Nausea—Fluorouracil—skin cancer	0.000321	0.000859	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—skin cancer	0.000319	0.000853	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—skin cancer	0.000308	0.000825	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—skin cancer	0.000308	0.000825	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—skin cancer	0.000287	0.000769	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—skin cancer	0.00028	0.000749	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—skin cancer	0.000276	0.000738	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—skin cancer	0.000267	0.000714	CcSEcCtD
Metoprolol—Dizziness—Docetaxel—skin cancer	0.000258	0.00069	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—skin cancer	0.000248	0.000663	CcSEcCtD
Metoprolol—Rash—Docetaxel—skin cancer	0.000246	0.000658	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—skin cancer	0.000246	0.000657	CcSEcCtD
Metoprolol—Headache—Docetaxel—skin cancer	0.000244	0.000654	CcSEcCtD
Metoprolol—Nausea—Docetaxel—skin cancer	0.000232	0.00062	CcSEcCtD
